Atlas Trials

Chronic Thalidomide Administration in Patients Undergoing Chemoembolization for Unresectable Hepatocellular Cancer

Clinical trial NCT00006198 · UNKNOWN

Trial details

NCT number
NCT00006198
Sponsor
National Center for Research Resources (NCRR)
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Liver Cancer

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.